Company: TVRD
Filing Date: 2025-05-30
Form Type: S-1
Source: 0001104659-25-054853
Chunk: 340

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-05-30
Form: S-1
Chunk 340
---
aggregation of Income Statement Expenses. The amendments in ASU 2024-03 address investor requests for more detailed expense information and require additional disaggregated disclosures in the notes to financial statements for certain categories of expenses that are included in the statement of operations. This guidance is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the provisions of this guidance and the potential impact on its financial statements and disclosures.

<div align='center'>F-36</div>

3.Fair Value Measurements

The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy used to determine such fair values (in thousands):

| ​                           
 ​                           
 ​                           | ​ 
 ​ 
 ​ | ​                             
 Fair Value Measurements as of 
 March 31, 2025                |      ​ | ​ | ​       | ​ | ​ | ​       |      ​ | ​ | ​     |      ​ |
|:----------------------------|:--|:------------------------------|-------:|:--|:--------|:--|:--|:--------|-------:|:--|:------|-------:|
| ​                           |   | Level 1                       |        |   | Level 2 |   |   | Level 3 |        |   | Total |        |
| Financial assets:           |   | ​                             |        |   | ​       |   |   | ​       |        |   | ​     |        |
| Cash equivalents:           |   | ​                             |        |   | ​       |   |   | ​       |        |   | ​     |        |
| Money market funds          | ​ | $                             | 10,708 | ​ | $       | — | ​ | $       |      — | ​ | $     | 10,708 |
| Short-term investments:     | ​ |                               |        | ​ |         |   | ​ |         |        | ​ |       |        |
| U.S. Treasury Notes         | ​ |                               | 10,871 | ​ |         | — | ​ |         |      — | ​ |       | 10,871 |
| Total financial assets      | ​ | $                             | 21,579 | ​ | $       | — | ​ | $       |      — | ​ | $